Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2004
   Review
2. Lifestyle management for type 2 diabetes. Are family physicians ready and willing?Canadian family physician Medecin de famille canadien · 2004
   Article
3. Lifestyle interventions for type 2 diabetes. Relevance for clinical practice.Canadian family physician Medecin de famille canadien · 2003
   Review
4. Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2000
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as